Title:
メラノコルチン3受容体(MC3R)作用薬ペプチドの用途
Document Type and Number:
Japanese Patent JP2006527772
Kind Code:
A
Abstract:
The present invention provides methods of treating metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, methods of inducing weight loss and increasing muscle mass in a patient, by administration of MC3R agonist peptides. Furthermore, the present invention provides the use of an MC3R agonist peptide for the manufacture of a medicament for the treatment of metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, inducing weight loss and increasing muscle mass in a patient.
Inventors:
Robert Alan Gadsky
Mark Lewis Hayman
Hansen Maxwell Shun
John Philip Mayer
Lian Zen Yang
Mark Lewis Hayman
Hansen Maxwell Shun
John Philip Mayer
Lian Zen Yang
Application Number:
JP2006517151A
Publication Date:
December 07, 2006
Filing Date:
June 17, 2004
Export Citation:
Assignee:
Eli Lilly and Company
International Classes:
A61K38/00; A61K38/12; A61P3/00; A61P3/04; A61P3/10; A61P7/00; A61P9/10; A61P21/00; A61P43/00; C07K11/02
Attorney, Agent or Firm:
Kyousei Tamura
Minato Saito
Nagatoshi Shinagawa
Minato Saito
Nagatoshi Shinagawa